Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2010
12/09/2010US20100310597 Anti-ofloxacin monoclonal antibody and immunoassay of ofloxacin using the same
12/09/2010US20100310596 Method and Compositions for Cutaneous Immunisation
12/09/2010US20100310593 Vaccines Against Chlamydia Infection
12/09/2010US20100310592 A truncated form of the hiv p17 protein
12/09/2010US20100310586 Idiotypic vaccine
12/09/2010US20100310585 The use of monomycolyl glycerol (mmg) as an adjuvant
12/09/2010US20100310576 COMPOSITIONS AND METHODS COMPRISING ASPARTYL-tRNA SYNTHETASES HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES
12/09/2010US20100310572 Binding molecules capable of neutralizing rabies virus and uses thereof
12/09/2010US20100310569 Genes of an Otitis Media Isolate of Nontypeable Haemophilus Influenzae
12/09/2010US20100310562 System for delivery into xcr1 positive cell and uses thereof
12/09/2010US20100310561 Natriuretic fusion proteins
12/09/2010US20100310555 Compositions with hematopoietic and immune activity
12/09/2010US20100310553 Compositions and Methods for Controlling Hepatitis C Virus Infection
12/09/2010US20100310545 Dry treatment mixture and methods of production and use
12/09/2010US20100310541 Compositions and Methods for Reducing the Toxicity of Certain Toxins
12/09/2010US20100310528 Vector System for Site-Specific Integration
12/09/2010US20100310522 Novel Polypeptides Having Endolysin Activity and Uses Thereof
12/09/2010US20100310516 Duplexed Parvovirus Vectors
12/09/2010US20100310513 Bifidobacterial species
12/09/2010US20100310512 Antiviral compounds
12/09/2010US20100310510 N-terminally chemically modified protein compositions and methods
12/09/2010US20100310502 Method of treating local infections in mammals
12/09/2010US20100310498 Active agents and their oligomers and polymers
12/09/2010US20100310487 Active ingredient combination and use thereof
12/09/2010US20100310476 Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
12/09/2010US20100310475 Biocide Capsules, Preparation Comprising them and Sanitary Pad Comprising the Preparation
12/09/2010US20100310465 Nano-devices having releasable seals for controlled release of molecules
12/09/2010US20100310464 Antibodies
12/09/2010DE202008017925U1 Arzneimittel aus Pflanzenrohstoffe zur Kongelationsprävention und Kongelationsbehandlung Drugs derived from plants and raw materials for Kongelationsprävention Kongelationsbehandlung
12/09/2010DE102009023559A1 Composition, useful for treating skin diseases e.g. atopic dermatitis, eczema, comprises ointment base for external use, jojoba oil, kaolin powder, sericite powder, fermented effective microorganism solution and Houttuynia cordata extract
12/09/2010DE102009023549A1 Use of hops for making a tea infusion and as auxiliary aid in nervousness, anxiety state, depression or sleep disorder, where debitterized hops are used
12/09/2010CA2841499A1 Compositions and methods for preventing sternal wound infections
12/09/2010CA2791580A1 Silk fibroin systems for antibiotic delivery
12/09/2010CA2764424A1 Vaccine for mycoplasma infection
12/09/2010CA2764158A1 Polynucleotides for multivalent rna interference, compositions and methods of use thereof
12/09/2010CA2763977A1 Human milk peptides
12/09/2010CA2763626A1 Recombinant production of peptides
12/09/2010CA2761854A1 Pharmaceutical compositions containing antifungal peptides
12/09/2010CA2761733A1 Reagents and methods for detecting influenza virus proteins
12/09/2010CA2761227A1 Borinic compositions
12/09/2010CA2760485A1 Borinic compositions
12/08/2010EP2258851A1 Combination neisserial compositions
12/08/2010EP2258842A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
12/08/2010EP2258718A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
12/08/2010EP2258712A2 Compositions and Methods to Initiate or Enhance Antibody and Major-histocompatibility Class I or Class II-restricted T Cell Responses by Using Immunomodulatory, Non-coding RNA Motifs
12/08/2010EP2258705A1 Pharmaceutically acceptable salts of anti-infective quinolone compound
12/08/2010EP2258694A1 Amines as histamine-3 receptor ligands and their therapeutic applications
12/08/2010EP2258687A1 Nicotinamide derivates useful as P38 inhibitors
12/08/2010EP2258681A2 Aromatic Derivatives as HIV Aspartyl Protease Inhibitors
12/08/2010EP2258680A2 Aromatic derivatives as HIV aspartyl protease inhibitors
12/08/2010EP2258415A2 Medical devices containing rapamycin analogs
12/08/2010EP2258392A1 Method of administering therapeutic polypeptides
12/08/2010EP2258387A2 Neisseria vaccine composition
12/08/2010EP2258386A2 Neisseria Vaccine composition
12/08/2010EP2258385A2 Neisseria vaccine composition
12/08/2010EP2258380A1 Substance and composition both capable of imparting heat resistance
12/08/2010EP2258376A1 Phosphonate analogs of HIV inhibitor compounds
12/08/2010EP2258365A1 Use of organic compounds for immunopotentiation
12/08/2010EP2258363A1 Compositions for treatment of cancers
12/08/2010EP2258356A2 Chemical compounds having antiviral activity against dengue virus and other flaviviruses
12/08/2010EP2258352A2 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
12/08/2010EP2257569A1 Method of treatment using antimicrobial composition
12/08/2010EP2257567A1 Novel 17 beta lupane derivatives
12/08/2010EP2257551A2 Azatricyclic antibiotic compounds
12/08/2010EP2257295A1 Photodynamic therapy process and photosensitizer compositions
12/08/2010EP2257294A2 Treatment of herpes virus related diseases
12/08/2010EP2257292A2 Zn/trimethoprim combination therapy
12/08/2010EP1937257B1 Novel antibiotics comprising bis(1-aryl-5-tetraz0lyl)methane derivatives
12/08/2010EP1857108B1 Preventive or therapeutic agent for herpesvirus-related disease
12/08/2010EP1848684B1 Ester-linked gemini surfactant compounds for use in gene therapy
12/08/2010EP1793844B1 Use of [d-meala]3-[etval]4-cyclosporin for the treatment of hepatitis c infection
12/08/2010EP1781290B1 Anti-inflammatory agents
12/08/2010EP1506285B1 Combinations of anti-dr5 antibodies and anti-dr4 antibodies and other therapeutic agents
12/08/2010EP1496109B1 Process for producing cytotoxic lymphocyte
12/08/2010EP1443958B1 Vaccine against infectious disease
12/08/2010EP1427750B1 Modified transferrin fusion proteins
12/08/2010EP1093457B1 Cytokine receptor common gamma chain like
12/08/2010EP0772619B2 Immunomodulatory oligonucleotides
12/08/2010CN201664142U Moxa good-smelling pillow for cerebral-heart comfort
12/08/2010CN1990482B Flavanonol compounds and their production method and use
12/08/2010CN1977892B Method for regulating baicalin and baicalein ratio in scutellariae root extract
12/08/2010CN1946411B Inhibition of biogenic sulfide production via biocide and metabolic inhibitor combination
12/08/2010CN1927197B Medical use of 1beta-keto-5, 11(13)-diene eudesmane-12-acid for inhibiting hepatitis B virus
12/08/2010CN1853644B Treatment and prophylaxis of diseases and infections pigs and poultry
12/08/2010CN1762357B Oral medicinal formulation of moxifloxacin and its preparation method
12/08/2010CN1679596B Dispersive composition of noncrystal Adifuwei ester and supplementary and preparation thereof
12/08/2010CN1671696B Kinase inhibitors
12/08/2010CN1660184B Combination of medicaiton containing extractive of herb of glabrous sarcandra, and preparation method and application
12/08/2010CN1650005B Antimicrobial polypeptide and utizliation thereof
12/08/2010CN1384884B Herpes virus vectors for dendritic cells
12/08/2010CN101910195A Macrocyclic inhibitors of hepatitis c virus NS3 serine protease
12/08/2010CN101910177A Macrocyclic indoles as hepatitis c virus inhibitors
12/08/2010CN101910159A Process for production of heterocycle-substituted pyridine derivative
12/08/2010CN101910145A Heterocyclic antiviral compounds
12/08/2010CN101910137A 1,3-dialkyl-benzimidazole halogenides exhibiting regeneration, anti-inflammatory and antimicrobial activity
12/08/2010CN101910125A Compounds from mycelium of antrodia cinnamomea and use thereof
12/08/2010CN101909653A Composition exhibiting high osmotic antimicrobial, anti-inflammatory and regeneration activity
12/08/2010CN101909650A Use of an acetylsalicylic acid salt for the treatment of viral infections
12/08/2010CN101909644A Prevention of opportunistic infections in immune-compromised subjects
12/08/2010CN101909641A Dental sterilizing water, method for producing the water, and device for producing the water
1 ... 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 ... 1798